Unknown

Dataset Information

0

Age-specific differences in oncogenic pathway deregulation seen in human breast tumors.


ABSTRACT: To define the biology driving the aggressive nature of breast cancer arising in young women.Among 784 patients with early stage breast cancer, using prospectively-defined, age-specific cohorts (young or=65 years), 411 eligible patients (n = 200or=65 years) with clinically-annotated Affymetrix microarray data were identified. GSEA, signatures of oncogenic pathway deregulation and predictors of chemotherapy sensitivity were evaluated within the two age-defined cohorts.In comparing deregulation of oncogenic pathways between age groups, a higher probability of PI3K (p = 0.006) and Myc (p = 0.03) pathway deregulation was observed in breast tumors arising in younger women. When evaluating unique patterns of pathway deregulation, a low probability of Src and E2F deregulation in tumors of younger women, concurrent with a higher probability of PI3K, Myc, and beta-catenin, conferred a worse prognosis (HR = 4.15). In contrast, a higher probability of Src and E2F pathway activation in tumors of older women, with concurrent low probability of PI3K, Myc and beta-catenin deregulation, was associated with poorer outcome (HR = 2.7). In multivariate analyses, genomic clusters of pathway deregulation illustrate prognostic value.Results demonstrate that breast cancer arising in young women represents a distinct biologic entity characterized by unique patterns of deregulated signaling pathways that are prognostic, independent of currently available clinico-pathologic variables. These results should enable refinement of targeted treatment strategies in this clinically challenging situation.

SUBMITTER: Anders CK 

PROVIDER: S-EPMC2148101 | biostudies-literature | 2008 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Purpose</h4>To define the biology driving the aggressive nature of breast cancer arising in young women.<h4>Experimental design</h4>Among 784 patients with early stage breast cancer, using prospectively-defined, age-specific cohorts (young <or=45 years; older >or=65 years), 411 eligible patients (n = 200<or=45 years; n = 211>or=65 years) with clinically-annotated Affymetrix microarray data were identified. GSEA, signatures of oncogenic pathway deregulation and predictors of chemotherapy sens  ...[more]

Similar Datasets

2008-01-16 | GSE7849 | GEO
| S-ECPF-GEOD-7849 | biostudies-other
2008-06-15 | E-GEOD-7849 | biostudies-arrayexpress
| S-EPMC5489359 | biostudies-literature
| S-EPMC2263127 | biostudies-literature
| S-ECPF-GEOD-8193 | biostudies-other
| S-EPMC3144998 | biostudies-literature
| S-EPMC4605991 | biostudies-literature
| S-EPMC5562753 | biostudies-literature
| S-EPMC7600338 | biostudies-literature